electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference

BASKING RIDGE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), ...

electroCore, Inc. Announces Third Quarter Financial Results

BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), ...

NICE publishes advice on gammaCore for the treatment of cluster headache in the UK

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of ...

Selecta Biosciences Announces Third Quarter 2018 Financial Results and Provides Corporate Update

 Prioritized head-to-head superiority clinical trial of SEL-212 compared to Krystexxa, expected to begin in ...

Corbus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Licensed Jenrin Discovery’s extensive library of small molecules targeting the endocannabinoid system (ECS) positioning ...

Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights

Company reported net ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) sales of $7.0 million in ...

Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results

Total First-Quarter Revenues of $202.3 Million, Up 13 PercentFirst-Quarter Diluted EPS of ($0.01) and ...

Endocannabinoids Demonstrate Efficacy in Lupus Model

Zylö’s Nanopod™ Delivery Technology Plays Key Role GREENVILLE, SC, Nov. 01, 2018 (GLOBE NEWSWIRE) ...